Douglas A. Andres

1993- Molecular and Cellular Biochemistry University of Kentucky, Lexington, KY 
"Douglas A. Andres"

Mean distance: (not calculated yet)


Sign in to add mentor
Jack E. Dixon grad student 1985-1990 Purdue
 (Characterization of the Carboxyl-terminal Sequences Responsible for Protein Retention in the Endoplasmic Reticulum.)
Michael Stuart Brown post-doc 1990-1993 UT Southwestern
Joseph L. Goldstein post-doc 1990-1993 UT Southwestern
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Young LEA, Conroy LR, Clarke HA, et al. (2022) In situ mass spectrometry imaging reveals heterogeneous glycogen stores in human normal and cancerous tissues. Embo Molecular Medicine. e16029
Andres DA, Young LEA, Gentry MS, et al. (2020) Spatial profiling of gangliosides in mouse brain by mass spectrometry imaging. Journal of Lipid Research
Ahern BM, Levitan BM, Veeranki S, et al. (2019) Myocardial-restricted ablation of the GTPase RAD results in a pro-adaptive heart response in mice. The Journal of Biological Chemistry
Mir S, Andres DA. (2018) Small GTPase RIT1 in Mouse Retina; Cellular and Functional Analysis. Current Eye Research
Withers CN, Brown DM, Byiringiro I, et al. (2017) Rad GTPase is essential for the regulation of bone density and bone marrow adipose tissue in mice. Bone
Mir S, Cai W, Carlson SW, et al. (2017) IGF-1 mediated Neurogenesis Involves a Novel RIT1/Akt/Sox2 Cascade. Scientific Reports. 7: 3283
Mir S, Cai W, Andres DA. (2016) RIT1 GTPase Regulates Sox2 Transcriptional Activity and Hippocampal Neurogenesis. The Journal of Biological Chemistry
Koenighofer M, Hung CY, McCauley JL, et al. (2015) Mutations in RIT1 cause Noonan syndrome - additional functional evidence and expanding the clinical phenotype. Clinical Genetics
Cai W, Andres DA. (2014) mTORC2 is required for rit-mediated oxidative stress resistance. Plos One. 9: e115602
Berger AH, Duke F, Imielinski M, et al. (2014) Abstract PR02: Recurrent oncogenic mutations in the small GTPaseRIT1activate PI3K and MEK. Clinical Cancer Research. 20: PR02-PR02
See more...